Dr. Yimin Hu joined Mingdu Zhiyun as the head of Zeeta Research Institute and Chief Scientist Officer.
Dr. Hu received his bachelor’s degree from Peking University, and PhD degree in Chemistry from Stanford University. He continued Postdoc research in organic chemistry at Harvard University for two years. Dr. Hu has more than 10 years’ experience in drug discovery and CMC development. He worked at GSK China R&D Center and Roche Innovation Center Shanghai, as Scientist to Principal Scientist in Medicinal Chemistry from 2009-2017. Dr. Hu served as Executive Director of CMC and the head of Suzhou site for small molecule development at Jiangsu Hengrui Medicine Co.,Ltd. from 2017-2022. Dr. Hu has been responsible for top level government sponsored projects in the area of pharmaceutical development. He has also received many awards and honors at different levels.
Dr. Hu will oversee the operation of Zeeta Research Institute, and explore interdisciplinary innovations enhanced with digital technologies. His knowledge and experience in drug discovery and development will strengthen the research capability for Mingdu, and promote next stage digital transformations for the pharmaceutical industry.